Reliability of [18F]-FTC-146 Brain Uptake in Healthy Controls

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

March 3, 2020

Study Completion Date

March 3, 2021

Conditions
Healthy Controls
Interventions
DRUG

[18F]-FTC-146

Two 5 mCi \[18F\]-FTC-146 doses will be administered intravenously on two separate scan days at least one week apart (total per study = 10 mCi) Participants who complete both test days will receive 10 mCi total dose; however, if a participant is unable to return for a second test day due to unforeseen circumstances, they will receive 5 mCi total dose.

Trial Locations (1)

94304

Department of Psychiatry and Behavioral Sciences, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT03649555 - Reliability of [18F]-FTC-146 Brain Uptake in Healthy Controls | Biotech Hunter | Biotech Hunter